Novartis Investigative Site

Jerez de la Frontera, Andalusia 11407

0 studies enrolling now · 2 studies all time

What they study most

Cardiovascular Disease, Heart Failure With Reduced Ejection Fraction (HF-rEF), Type 2 Diabetes Mellitus

Studies at this site

• Multiple Patient Program to Ensure Access to LCZ696 Treatment to Patients Diagnosed With Heart Failure With Reduced Ejection Fraction (HF-rEF) — NO_LONGER_AVAILABLE
• Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) — Stopped early